L61H46 Shows Potent Efficacy Against Human Pancreatic Cancer Through Inhibiting STAT3 Pathway [Erratum]

This article refers to:

L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway

Bai E, Yang L, Xiang Y, et al. Cancer Manag Res. 2018;10:565–581.

During the publication process there was an operator error that resulted in the Western blot images of Figures 5A and 5B on page 575 appearing spliced.

The original images provided by the authors were not spliced and the correct figure is shown below. The corrections do not impact the findings of the study.